Company CNS RESP OTC Bulletin Board
Equities
CNSOD
US12619C2008
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 21 | 100.0 % | 18 | 100.0 % | -10.77% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 21 | 100.0 % | 18 | 100.0 % | -10.77% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
George Sekulich
PSD | President | 59 | 30/04/19 |
Willis Lee
CHM | Chairman | 64 | 16/07/19 |
Yasushi Nagasaki
DFI | Director of Finance/CFO | 57 | 30/04/11 |
Mark Diamond
CIO | Chief Investment Officer | - | - |
Charles Stark
CTO | Chief Tech/Sci/R&D Officer | 68 | 31/12/12 |
Lan T. Tran
ADM | Chief Administrative Officer | 48 | 16/07/19 |
Dale E. Short
SEC | Corporate Secretary | - | 31/08/18 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Wei Peu Zen
BRD | Director/Board Member | 71 | 16/07/19 |
Willis Lee
CHM | Chairman | 64 | 16/07/19 |
Ian Zwicker
BRD | Director/Board Member | 77 | 16/07/19 |
George Sekulich
PSD | President | 59 | 30/04/19 |
Seah LIm
BRD | Director/Board Member | 66 | 03/10/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 53,637,554 | 25,870,168 ( 48.23 %) | 0 | 48.23 % |
Company contact information
Emmaus Life Sciences, Inc.
21250 Hawthorne Boulevard Suite 800
90503, Torrance
+
http://www.emmausmedical.comSector
1st Jan change | Capi. | |
---|---|---|
+46.19% | 55.7B | |
+40.12% | 39.91B | |
-6.14% | 39.57B | |
-6.65% | 28.16B | |
+12.33% | 26.3B | |
-21.78% | 18.94B | |
+28.38% | 12.17B | |
+24.18% | 12.12B | |
-0.35% | 12.12B |